Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)

BARLESI, Fabrice ; SCHERPEREEL, Arnaud ; WONG, Elaine K ; PEREZ-MORENO, Pablo ; MITCHELL, Lada ; GROEN, Harry J. M ; RITTMEYER, Achim ; PAZZOLA, Antonio ; FERRER TUR, Neus ; KIM, Joo-Hang ; AHN, Myung-Ju ; AERTS, Joachim G. J. V ; GORBUNOVA, Vera ; VIKSTRÖM, Anders

Journal of clinical oncology, 2013-08, Vol.31 (24), p.3004-3011 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível